Is there an oral medication to treat hypotension by raising blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Medications to Raise Blood Pressure in Hypotension

Yes, there are oral medications available to treat hypotension by raising blood pressure, with midodrine being the only FDA-approved oral agent specifically for this indication, though droxidopa and fludrocortisone are also used in clinical practice. 1, 2

FDA-Approved Oral Pressor Agents

Midodrine (First-Line Oral Agent)

  • Midodrine is an oral selective α1-adrenergic agonist that raises blood pressure by increasing peripheral vascular resistance through arteriolar and venular vasoconstriction. 1
  • The medication should be administered within 30 minutes of initiating hemodialysis for intradialytic hypotension, or upon awakening and midday for orthostatic hypotension. 1
  • Midodrine works by enhancing venous return and cardiac output in addition to peripheral vasoconstriction. 1
  • The drug is well-tolerated with few side effects, making it the most widely used oral pressor agent, though its availability is limited outside the United States. 1
  • Dosing should be at the lowest dose and frequency that improves symptoms rather than targeting a specific blood pressure number. 3

Droxidopa (Alternative FDA-Approved Agent)

  • Droxidopa is FDA-approved for treating orthostatic hypotension and works as a prodrug converted to norepinephrine. 1, 2
  • The medication can be used when midodrine is ineffective or not tolerated. 3
  • Important drug interaction warning: Droxidopa increases the risk of supine hypertension when combined with other blood pressure-raising agents including norepinephrine, ephedrine, midodrine, and triptans. 2
  • Non-selective MAO inhibitors and linezolid should be avoided with droxidopa due to potential for excessive blood pressure elevation. 2

Off-Label Oral Agents

Fludrocortisone (Mineralocorticoid)

  • Fludrocortisone works by expanding blood volume through sodium and water retention, making it particularly useful for volume-depleted patients. 4, 5
  • This agent is commonly used in combination with midodrine for enhanced effect. 4
  • The medication addresses the volume component of hypotension rather than providing direct vasoconstriction. 5

Alternative Agents with Limited Evidence

  • Pyridostigmine facilitates cholinergic neurotransmission in autonomic ganglia and can improve upright blood pressure by harnessing residual sympathetic tone. 3
  • Atomoxetine blocks norepinephrine reuptake in nerve terminals, providing another mechanism to raise blood pressure without traditional pressor effects. 3
  • Sertraline has been studied for intradialytic hypotension but has limited evidence. 1
  • Carnitine has been investigated but evidence remains weak. 1

Non-Pharmacologic Strategies (Essential Adjuncts)

Drug therapy alone is never adequate for managing hypotension—patient education and non-pharmacologic measures are critical components of treatment. 5

Volume Expansion Strategies

  • Ensuring adequate salt intake (6-9 grams daily) and fluid consumption (2-3 liters daily) unless contraindicated by heart failure. 6
  • Oral water bolus (approximately 500 mL) acutely but transiently increases blood pressure in autonomic failure patients. 3

Physical Countermeasures

  • Abdominal binders can prevent orthostatic hypotension without needing to increase baseline blood pressure. 3
  • Elevating the head of the bed by 10 degrees during sleep prevents nocturnal polyuria and maintains favorable fluid distribution. 6
  • Compression garments over legs and abdomen provide mechanical support. 1

Medication Review (Critical First Step)

  • Remove drugs that worsen hypotension before adding pressor agents, including easily overlooked medications such as tamsulosin, tizanidine, sildenafil, trazodone, and carvedilol. 3
  • Alpha-1 blockers (doxazosin, prazosin, terazosin) are strongly associated with orthostatic hypotension and should be avoided. 6
  • Centrally-acting agents (clonidine, methyldopa, guanfacine) should be reserved as last-line due to significant CNS adverse effects and orthostatic hypotension risk. 6

Substances That Can Raise Blood Pressure (Not Therapeutic)

While not recommended as therapeutic agents, certain substances can increase blood pressure and should be noted:

  • Pseudoephedrine hydrochloride may be safe in small doses, though phenylpropanolamine and ephedrine sulfate are best avoided. 7
  • Nasal phenylephrine is probably the safest adrenergic agent if such medications must be used. 7
  • NSAIDs, particularly ibuprofen at maximum over-the-counter doses for more than a few days, can elevate blood pressure. 1, 7

Treatment Goals and Monitoring

The therapeutic goal is to minimize postural symptoms and prevent falls rather than to restore normotension, as aggressive blood pressure targets can lead to supine hypertension. 1, 4

  • There is no predefined blood pressure target—treatment success is measured by symptom relief and functional improvement. 4, 5
  • Standing time and ability to perform daily activities are more important outcomes than specific blood pressure numbers. 5
  • Supine blood pressure tends to be much higher in patients with orthostatic hypotension, often requiring separate management with shorter-acting antihypertensives at bedtime. 1

Common Pitfalls to Avoid

  • Never rely on medication alone—a patient-oriented approach emphasizing education and non-pharmacologic strategies is essential because orthostatic stress varies throughout the day. 5
  • Avoid using pressor agents at higher doses than necessary, as this increases the risk of supine hypertension. 3
  • Do not overlook medication-induced hypotension as the first and most reversible cause. 3, 4
  • Recognize that hypovolemia is a major contributor to non-neurogenic orthostatic hypotension and must be addressed before adding pressor agents. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Orthostatic Hypotension in the Hypertensive Patient.

American journal of hypertension, 2018

Research

Orthostatic hypotension: A review.

Nephrologie & therapeutique, 2017

Research

Preventing and treating orthostatic hypotension: As easy as A, B, C.

Cleveland Clinic journal of medicine, 2010

Guideline

Management of Bisoprolol-Induced Orthostatic Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the considerations for using prazosin in an elderly patient with hypertension and a history of orthostatic hypotension?
Is a blood pressure of 169/83 mmHg while lying down a concern for an elderly male with a history of drug-induced hypotension two days ago and not currently on blood pressure (BP) medications?
What to do for asymptomatic hypotension with a blood pressure reading of 74/47 mmHg?
What are the recommendations for managing orthostatic hypotension in a patient with a complex medical history including CKD, heart failure with preserved ejection fraction, and significantly elevated TSH, currently on minidrin and fludrocortisone?
How to manage a 68-year-old male patient with hypertension (HTN) on Lisinopril (Zestril) 40 mg, Metoprolol (Lopressor) 50 mg, and Amlodipine (Norvasc) 10 mg, who experiences daily lightheadedness, particularly with positional changes, and is undergoing orthostatic blood pressure measurement?
What antibiotic regimen is appropriate for an adult with an infected sebaceous (epidermoid) cyst, including options for MRSA coverage?
What is the recommended treatment for body acne?
What is the recommended management of a non‑inflamed sebaceous (epidermoid) cyst in an otherwise healthy adult?
What is the systematic diagnostic workup for confirming multiple myeloma?
What is selective nephron blockade and what diuretic regimen and monitoring should be used in an adult patient with resistant hypertension or volume overload?
What is the appropriate management of an inflamed sebaceous (epidermoid) cyst, including acute infection treatment and definitive removal?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.